Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Published in: Inflammation Research 7/2018

01-07-2018 | Review

A review on heme oxygenase-1 induction: is it a necessary evil

Authors: Ajaz Ahmad Waza, Zeenat Hamid, Sajad Ali, Shabir Ahmad Bhat, Musadiq Ahmad Bhat

Published in: Inflammation Research | Issue 7/2018

Login to get access

Abstract

Heme oxygenase-1 (HO-1) is considered to be the main protein in diseases arising as a result of oxidative and inflammatory insults. Tremendous research has been carried out on HO-1 since years, pertaining its cytoprotective effect against oxidative injury and other cellular stresses. HO-1, by regulating intracellular levels of pro-oxidant heme, or by other benefits of its by-products such as carbon monoxide (CO) and biliverdin (BV) had become an important candidate protein to be up-regulated to combat diverse stressful events. Although the beneficial effects of HO-1 induction have been reported in a number of cells and tissues, a growing body of evidence indicates that this increased HO-1 expression may lead to the progression of several diseases such as neurodegeneration, carcinogenesis. But it is not clear, what accounts for the increased expression of HO-1 in cells and tissues. The observed friendly role of HO-1 in a wide range of stress conditions since times is now doubtful. Therefore, more studies are needed to elucidate the exact role of HO-1 in various stressful events. Being more concise, elucidating the effect of HO-1 up-regulation on critical genes involved in particular diseases such as cancer will help to a larger extent to comprehend the exact role of HO-1. This review will assist in understanding the dual role (protective and detrimental) of HO-1 and the signaling pathway involved and will help in unraveling the doubtful role of HO-1 induction.
Literature
1.
Maines MD, Gibbs PE. 30 some years of heme oxygenase: from a “molecular wrecking ball” to a “mesmerizing” trigger of cellular events. Biochem Biophys Res Commun. 2005;338:568–77.CrossRefPubMed
2.
Nitti M, Piras S, Marinari UM, Moretta L, Pronzato MA, Furfaro AL. HO-1 induction in cancer progression: a matter of cell adaptation. Antioxidants. 2017;6:29.CrossRefPubMedCentral
3.
Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, Noguchi M. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene. 2004;336:241–50.CrossRefPubMed
4.
Lin Q, Weis S, Yang G, Weng YH, Helston R, et al. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem. 2007;282:20621–33.CrossRefPubMed
5.
Slebos DJ, Ryter SW, van der Toorn M, Liu F, Guo F, et al. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol. 2007;36:409–17.CrossRefPubMed
6.
Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, et al. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol. 2004;165:1045–53.CrossRefPubMedPubMedCentral
7.
Bindu S, Pal C, Dey S, Goyal M, Alam A, et al. Translocation of heme oxygenase-1 to mitochondria is a novel cytoprotective mechanism against non-steroidal anti-inflammatory drug-induced mitochondrial oxidative stress, apoptosis, and gastric mucosal injury. J Biol Chem. 2011;286:39387–402.CrossRefPubMedPubMedCentral
8.
Sacca P, Meiss R, Casas G, Mazza O, Calvo JC, et al. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer. 2007;97:1683–9.CrossRefPubMedPubMedCentral
9.
Hsu FF, Yeh CT, Sun YJ, Chiang MT, Lan WM, et al. Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity. Oncogene. 2015;34:2360–70.CrossRefPubMed
10.
Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86:583–650.CrossRefPubMed
11.
Son Y, Lee JH, Chung HT, Pae HO. Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1. Oxid Med Cell Longev. 2013;2013:639541.CrossRefPubMedPubMedCentral
12.
Li Volti G, Sacerdoti D, Di Giacomo C, Barcellona ML, Scacco A, et al. Natural heme oxygenase-1 inducers in hepatobiliary function. World J Gastroenterol. 2008;14:6122–32.CrossRefPubMed
13.
Doberer D, Haschemi A, Andreas M, Zapf TC, Clive B, et al. Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects. Br J Pharmacol. 2010;161:1751–62.CrossRefPubMedPubMedCentral
14.
Guijarro-Munoz I, Compte M, Alvarez-Cienfuegos A, Alvarez-Vallina L, Sanz L. Lipopolysaccharide activates toll-like receptor 4 (TLR4)-mediated NF-kappaB signaling pathway and proinflammatory response in human pericytes. J Biol Chem. 2014;289:2457–68.CrossRefPubMed
15.
16.
Konrad FM, Knausberg U, Hone R, Ngamsri KC, Reutershan J. Tissue heme oxygenase-1 exerts anti-inflammatory effects on LPS-induced pulmonary inflammation. Mucosal Immunol. 2016;9:98–111.CrossRefPubMed
17.
Lee JH, Jung NH, Lee BH, Kim SH, Jun JH. Suppression of heme oxygenase-1 by prostaglandin E2-protein kinase A-A-kinase anchoring protein signaling is central for augmented cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Allergy Asthma Immunol Res. 2013;5:329–36.CrossRefPubMedPubMedCentral
18.
Rushworth SA, MacEwan DJ, O’Connell MA. Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes. J Immunol. 2008;181:6730–7.CrossRefPubMedPubMedCentral
19.
Camhi SL, Alam J, Wiegand GW, Chin BY, Choi AM. Transcriptional activation of the HO-1 gene by lipopolysaccharide is mediated by 5′ distal enhancers: role of reactive oxygen intermediates and AP-1. Am J Respir Cell Mol Biol. 1998;18:226–34.CrossRefPubMed
20.
21.
22.
Pae HO, Jeong GS, Jeong SO, Kim HS, Kim SA, et al. Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells. Exp Mol Med. 2007;39:267–77.CrossRefPubMed
23.
Kim SY, Park E, Park JA, Choi BS, Kim S, et al. The plant phenolic diterpene carnosol suppresses sodium nitroprusside-induced toxicity in c6 glial cells. J Agric Food Chem. 2010;58:1543–50.CrossRefPubMed
24.
Kundu J, Chae IG, Chun KS. Fraxetin induces heme oxygenase-1 expression by activation of Akt/Nrf2 or AMP-activated protein kinase alpha/Nrf2 pathway in HaCaT cells. J Cancer Prev. 2016;21:135–43.CrossRefPubMedPubMedCentral
25.
Farombi EO, Surh YJ. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol. 2006;39:479–91.PubMed
26.
Alam J, Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol. 2007;36:166–74.CrossRefPubMed
27.
Immenschuh S, Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol. 2000;60:1121–8.CrossRefPubMed
28.
Chen HG, Xie KL, Han HZ, Wang WN, Liu DQ, Wang GL, Yu YH. Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages. Int J Surg. 2013;11:1060–6.CrossRefPubMed
29.
Otterbein LE, Bach FH, Alam J, Soares M, Tao H, Lu, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422–8.CrossRefPubMed
30.
Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem. 2003;278:36993–8.CrossRefPubMed
31.
Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8:240–6.CrossRefPubMed
32.
Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, et al. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res. 1999;85:663–71.CrossRefPubMed
33.
Ndisang JF, Jadhav A. Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab. 2009;296:E829–41.CrossRefPubMed
34.
Galeotti C, Hegde P, Das M, Stephen-Victor E, Canale F, et al. Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin. Sci Rep. 2016;6:19592.CrossRefPubMedPubMedCentral
35.
Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L. Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid Med Cell Longev. 2017;2017:2525967.PubMedPubMedCentral
36.
Chen J. Heme oxygenase in neuroprotection: from mechanisms to therapeutic implications. Rev Neurosci. 2014;25:269–80.CrossRefPubMed
37.
Chen K, Gunter K, Maines MD. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem. 2000;75:304–13.CrossRefPubMed
38.
Takeda A, Perry G, Abraham NG, Dwyer BE, Kutty RK, et al. Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J Biol Chem. 2000;275:5395–9.CrossRefPubMed
39.
Hung SY, Liou HC, Kang KH, Wu RM, Wen CC, et al. Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol Pharmacol. 2008;74:1564–75.CrossRefPubMed
40.
Sun GY, Chen Z, Jasmer KJ, Chuang DY, Gu Z, Hannink M, Simonyi A. Quercetin attenuates inflammatory responses in BV-2 microglial cells: role of MAPKs on the Nrf2 pathway and induction of heme oxygenase-1. PloS One. 2015;10:e0141509.CrossRefPubMedPubMedCentral
41.
Vairano M, Dello Russo C, Pozzoli G, Tringali G, Preziosi P, Navarra P. A functional link between heme oxygenase and cyclo-oxygenase activities in cortical rat astrocytes. Biochem Pharmacol. 2001;61:437–41.CrossRefPubMed
42.
Chen-Roetling J, Regan RF. Effect of heme oxygenase-1 on the vulnerability of astrocytes and neurons to hemoglobin. Biochem Biophys Res Commun. 2006;350:233–7.CrossRefPubMedPubMedCentral
43.
Song W, Patel A, Han D, Paudel HK, Schipper HM. Heme oxygenase-1 promotes proteosomal degradation of tau and alpha-synuclein in human neuroblastoma cells. Alzheimer Assoc. 2008; 4(Supplement):T410.
44.
Bolisetty S, Traylor A, Zarjou A, Johnson MS, Benavides GA, et al. Mitochondria-targeted heme oxygenase-1 decreases oxidative stress in renal epithelial cells. Am J Physiol Renal Physiol. 2013;305:F255–64.CrossRefPubMedPubMedCentral
45.
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, et al. American Heart Association Statistics, S. Stroke Statistics. Heart disease and stroke statistics–2011 update: a report from the. American Heart Association. Circulation. 2011;123:e18–e209.CrossRefPubMed
46.
Ewing JF, Raju VS, Maines MD. Induction of heart heme oxygenase-1 (HSP32) by hyperthermia: possible role in stress-mediated elevation of cyclic 3′:5′-guanosine monophosphate. J Pharmacol Exp Ther. 1994;271:408–14.PubMed
47.
Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest. 1999;103:R23–29.CrossRefPubMedPubMedCentral
48.
Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001;89:168–73.CrossRefPubMed
49.
Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, et al. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation. 2010;121:1912–25.CrossRefPubMedPubMedCentral
50.
Tang YL, Qian K, Zhang YC, Shen L, Phillips MI. A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J Cardiovasc Pharmacol Ther. 2005;10:251–63.CrossRefPubMed
51.
Schillaci G, Pirro M, Ronti T, Gemelli F, Pucci G, et al. Prognostic impact of prolonged ventricular repolarization in hypertension. Arch Int Med. 2006;166:909–13.CrossRef
52.
Mordukhovich I, Kloog I, Coull B, Koutrakis P, Vokonas P, Schwartz J. Association between particulate air pollution and QT interval duration in an elderly cohort. Epidemiology. 2016;27:284–90.PubMedPubMedCentral
53.
Grochot-Przeczek A, Kotlinowski J, Kozakowska M, Starowicz K, Jagodzinska J, et al. Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization. Antioxid Redox Signal. 2014;20:1677–92.CrossRefPubMedPubMedCentral
54.
Pirro M, Schillaci G, Romagno PF, Mannarino MR, Bagaglia F, et al. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function. J Cardiovasc Pharmacol Ther. 2009;14:14–21.CrossRefPubMed
55.
Lin HH, Chen YH, Yet SF, Chau LY. After vascular injury, heme oxygenase-1/carbon monoxide enhances re-endothelialization via promoting mobilization of circulating endothelial progenitor cells. J Thromb Haemost JTH. 2009;7:1401–8.CrossRefPubMed
56.
Bianconi V, Sahebkar A, Kovanen P, Bagaglia F, Ricciuti B, et al. Endothelial and cardiac progenitor cells for cardiovascular repair: a controversial paradigm in cell therapy. Pharmacol Ther. 2018;181:156–68.CrossRefPubMed
57.
Sikorski EM, Hock T, Hill-Kapturczak N, Agarwal A. The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol. 2004;286:F425–441.CrossRefPubMed
58.
59.
Feitoza CQ, Goncalves GM, Bertocchi AP, Wang PW, Damiao MJ, et al. A role for HO-1 in renal function impairment in animals subjected to ischemic and reperfusion injury and treated with immunosuppressive drugs. Transp Proc. 2007;39:424–6.CrossRef
60.
Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, et al. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension. 2000;35:800–6.CrossRefPubMed
61.
Aycan-Ustyol E, Kabasakal M, Bekpinar S, Alp-Yildirim FI, Tepe O, et al. Vascular function and arginine and dimethylarginines in gentamicin-induced renal failure: a possible effect of heme oxygenase 1 inducer hemin. Can J Physiol Pharmacol. 2017;95:1406–13.CrossRefPubMed
62.
Origassa CS, Camara NO. Cytoprotective role of heme oxygenase-1 and heme degradation derived end products in liver injury. World J Hepatol. 2013;5:541–9.CrossRefPubMedPubMedCentral
63.
McNally SJ, Harrison EM, Ross JA, Garden OJ, Wigmore SJ. Curcumin induces heme oxygenase-1 in hepatocytes and is protective in simulated cold preservation and warm reperfusion injury. Transplantation. 2006;81:623–6.CrossRefPubMed
64.
Waza. AA, Hamid Z. Majoon-e-Dabeed-ul-Ward protects lung cells against ethanol-induced cell death and activates Nrf2/HO-1 signaling pathway. Int J Res BioSci. 2018;7:1–7.
65.
McCarter SD, Badhwar A, Scott JR, Akyea TG, Bihari A, et al. Remote liver injury is attenuated by adenovirus-mediated gene transfer of heme oxygenase-1 during the systemic inflammatory response syndrome. Microcirculation. 2004;11:587–95.CrossRefPubMed
66.
Sass G, Soares MC, Yamashita K, Seyfried S, Zimmermann WH, et al. Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology. 2003;38:909–18.CrossRefPubMed
67.
Wu H, Zhang G, Huang L, Pang H, Zhang N, Chen Y, Wang G. Hepatoprotective effect of polyphenol-enriched fraction from folium microcos on oxidative stress and apoptosis in acetaminophen-induced liver injury in mice. Oxid Med Cell Longev. 2017;2017:3631565.PubMedPubMedCentral
68.
Tiwari S, Ndisang JF. The heme oxygenase system and type-1 diabetes. Curr Pharm Des. 2014;20:1328–37.CrossRefPubMed
69.
Lee EM, Lee YE, Lee E, Ryu GR, Ko SH, et al. Protective effect of heme oxygenase-1 on high glucose-induced pancreatic beta-cell injury. Diabetes Metab J. 2011;35:469–79.CrossRefPubMedPubMedCentral
70.
Castany S, Carcole M, Leanez S, Pol O. The induction of heme oxygenase 1 decreases painful diabetic neuropathy and enhances the antinociceptive effects of morphine in diabetic mice. PloS One. 2016;11:e0146427.CrossRefPubMedPubMedCentral
71.
Prawan A, Kundu JK, Surh YJ. Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid Redox Signal. 2005;7:1688–703.CrossRefPubMed
72.
Abdalla MY, Ahmad IM, Switzer B, Britigan BE. Induction of heme oxygenase-1 contributes to survival of Mycobacterium abscessus in human macrophages-like THP-1 cells. Redox Biol. 2015;4:328–39.CrossRefPubMedPubMedCentral
73.
Genter MB, Burman DM, Vijayakumar S, Ebert CL, Aronow BJ. Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa. Physiol Genom. 2002;12:35–45.CrossRef
74.
Gong P, Hu B, Cederbaum AI. Diallyl sulfide induces heme oxygenase-1 through MAPK pathway. Arch Biochem Biophys. 2004;432:252–60.CrossRefPubMed
75.
Nuhn P, Kunzli BM, Hennig R, Mitkus T, Ramanauskas T, et al. Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo. Mol Cancer. 2009;8:37.CrossRefPubMedPubMedCentral
76.
Dulak J, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation. 2008;117:231–41.CrossRefPubMedPubMedCentral
77.
Goswami A, Ranganathan P, Rangnekar VM. The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target. Cancer Res. 2006;66:2889–92.CrossRefPubMed
78.
Banerjee P, Basu A, Wegiel B, Otterbein LE, Mizumura K, et al. Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis- and autophagy-regulating molecules. J Biol Chem. 2012;287:32113–23.CrossRefPubMedPubMedCentral
79.
Andreadi CK, Howells LM, Atherfold PA, Manson MM. Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol Pharmacol. 2006;69:1033–40.PubMed
80.
Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, Dulak J. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal. 2003;5:155–62.CrossRefPubMed
81.
Mayerhofer M, Florian S, Krauth MT, Aichberger KJ, Bilban M, et al. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res. 2004;64:3148–54.CrossRefPubMed
82.
Nowis D, Legat M, Grzela T, Niderla J, Wilczek E, et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene. 2006;25:3365–74.CrossRefPubMedPubMedCentral
83.
Hirai K, Sasahira T, Ohmori H, Fujii K, Kuniyasu H. Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer. 2007;120:500–5.CrossRefPubMed
84.
Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A. Curcumin as a microRNA regulator in cancer: a review. Rev Physiol Biochem Pharmacol. 2016;171:1–38.CrossRefPubMed
85.
Ghattas MH, Chuang LT, Kappas A, Abraham NG. Protective effect of HO-1 against oxidative stress in human hepatoma cell line (HepG2) is independent of telomerase enzyme activity. Int J Biochem Cell Biol. 2002;34:1619–28.CrossRefPubMed
86.
Murakami A, Fujimori Y, Yoshikawa Y, Yamada S, Tamura K, et al. Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma. Lung. 2012;190:333–7.CrossRefPubMed
87.
Kikuchi A, Yamaya M, Suzuki S, Yasuda H, Kubo H, et al. Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet. 2005;116:354–60.CrossRefPubMed
88.
Sawa T, Mounawar M, Tatemichi M, Gilibert I, Katoh T, Ohshima H. Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-1 and the inducible nitric oxide synthase gene promoters. Cancer Lett. 2008;269:78–84.CrossRefPubMed
89.
Schipper HM, Cisse S, Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol. 1995;37:758–68.CrossRefPubMed
90.
Yu X, Song N, Guo X, Jiang H, Zhang H, Xie J. Differences in vulnerability of neurons and astrocytes to heme oxygenase-1 modulation: implications for mitochondrial ferritin. Sci Rep. 2016;6:24200.CrossRefPubMedPubMedCentral
91.
Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D. Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem. 2009;110:469–85.CrossRefPubMed
92.
93.
94.
95.
Kadoya C, Domino EF, Yang GY, Stern JD, Betz AL. Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats. Stroke. 1995;26:1035–8.CrossRefPubMed
96.
Lee DW, Gelein RM, Opanashuk LA. Heme-oxygenase-1 promotes polychlorinated biphenyl mixture aroclor 1254-induced oxidative stress and dopaminergic cell injury. Toxicol Sci. 2006;90:159–67.CrossRefPubMed
97.
Ursu ON, Sauter M, Ettischer N, Kandolf R, Klingel K. Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus B3-induced myocarditis. Cell Physiol Biochem. 2014;33:52–66.CrossRefPubMed
98.
Kang J, Jeong MG, Oh S, Jang EJ, Kim HK, Hwang ES. A FoxO1-dependent, but NRF2-independent induction of heme oxygenase-1 during muscle atrophy. FEBS Lett. 2014;588:79–85.CrossRefPubMed
Metadata
Title
A review on heme oxygenase-1 induction: is it a necessary evil
Authors
Ajaz Ahmad Waza
Zeenat Hamid
Sajad Ali
Shabir Ahmad Bhat
Musadiq Ahmad Bhat
Publication date
01-07-2018
Publisher
Springer International Publishing
Published in
Inflammation Research / Issue 7/2018
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-018-1151-x

Other articles of this Issue 7/2018

Inflammation Research 7/2018 Go to the issue

Review

Soluble TREM-1 as a predictive factor of neonatal sepsis: a meta-analysis

Original Research Paper

Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis

Original Research Paper

Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients

Original Research Paper

Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH)

Review

Inflammation, a significant player of Ataxia–Telangiectasia pathogenesis?

Short Communication

Expression analysis of toll-like receptors of Dengue-infected cornea by real-time polymerase chain reaction
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits